InvestorsHub Logo
Followers 8
Posts 1427
Boards Moderated 0
Alias Born 06/30/2016

Re: fabius post# 24404

Saturday, 02/25/2017 10:26:35 AM

Saturday, February 25, 2017 10:26:35 AM

Post# of 38634
Fabius.....I agree. first, its a rumor. but I will say rumors are based usually on something. the last time we had a rumor regarding a buyout and it turned out to be the MNK deal was right around the corner. so possibly a deal for the remaining generics? or we do know they have been in talks regarding Rexista.

Personally, the way they talked at the last conference if Regabatin would be part of the deal they would have said something more like, "we are in or actively seeking to partner to further the drug" not make a statement its shelved until it is partnered. but it would make sense that Novartis would be interested in it to protect against Lyrica. Lyrica is going to go generic so whats better but to come out with a better upgrade of the drug to combat the generic threat?

regarding the details of the rumor, I do agree. while an additional 10 million shares would be dilutive, it then takes the total upfront to 85 to 90 million level depending on the 20 MDA. thats an automatic $2 to $3 per share value! and then lets not forget thats just the beginning, there are going to be additional milestones so the entire deal may be worth upwards of 400 million along with split in royalties.

plus the additional benefit is we would then have a huge shareholder whose input would be valued at directors meetings and that could then stop stupid management decisions such as bonuses for drug approvals which then don't get or cant get commercialized.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y